Relationship between A2A Adenosine Receptor Expression and Intradialytic Hypotension during Hemodialysis

2006 ◽  
Vol 54 (8) ◽  
pp. 473-477 ◽  
Author(s):  
Philippe Giaime ◽  
Louis Carrega ◽  
Emmanuel Fenouillet ◽  
Laurence Mercier ◽  
Victoria Gerolami ◽  
...  
2005 ◽  
Vol 391 (3) ◽  
pp. 575-580 ◽  
Author(s):  
Lauren J. Murphree ◽  
Gail W. Sullivan ◽  
Melissa A. Marshall ◽  
Joel Linden

The A2A adenosine receptor (A2AAR) mediates anti-inflammatory actions of adenosine in a variety of cell types. LPS (lipopolysaccharide) was reported to induce a small (<2-fold) increase in the expression of A2AAR mRNA in human monocytes and monocytic cell lines. We investigated the effects of LPS on the expression of adenosine receptor mRNAs in primary mouse IPMΦ (intraperitoneal macrophages), human macrophages and Wehi-3 cells. Treatment with 10 ng/ml LPS for 4 h produced a >100-fold increase in A2AAR mRNA. LPS-induced increases in mRNA for A2AAR and TNFα (tumour necrosis factor α) are reduced by 90% in IPMΦ pretreated with the NF-κB (nuclear factor κB) inhibitor, BAY 11-7082 {(E)3-[(4-methylphenyl)sulphonyl]-2-propenenitrile; 10 μM}. In Wehi-3 cells exposed to LPS, A2AAR and A2BAR transcripts are elevated by 290- and 10-fold respectively, the A1AR transcript is unchanged and the A3AR transcript is decreased by 67%. The induction of A2AAR mRNA by LPS is detectable after 1 h, reaches a peak at 6 h at 600 times control and remains elevated beyond 24 h. The ED50 (effective dose) of LPS is 2.3 ng/ml. A2AAR receptor number, measured by 125I-ZM241385 binding to whole cells, is undetectable in naïve cells and increases linearly at a rate of 23 receptors·cell−1·min−1 to a Bmax of 348 fmol/mg (28000 receptors/cell) in 20 h. The increase in receptor number is correlated with an increase in the potency of an A2A agonist (4-{3-[6-amino-9-(5-ethylcarbamoyl-3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-cyclohexanecarboxylic acid methyl ester; referred to as ATL146e) to stimulate cAMP in these cells. After LPS pretreatment, the potency of the A2A agonist, ATL146e, to reduce TNFα release from IPMΦ was increased by 200-fold. The results support the hypothesis that regulation of adenosine receptor expression, especially up-regulation of the A2AAR, is part of a delayed feedback mechanism initiated through NF-κB to terminate the activation of human and mouse macrophages.


Oncotarget ◽  
2017 ◽  
Vol 8 (5) ◽  
pp. 8738-8751 ◽  
Author(s):  
Yusuke Inoue ◽  
Katsuhiro Yoshimura ◽  
Nobuya Kurabe ◽  
Tomoaki Kahyo ◽  
Akikazu Kawase ◽  
...  

2005 ◽  
Vol 11 (1) ◽  
pp. 67-73 ◽  
Author(s):  
Pier leopoldo Capecchi ◽  
Alessandra Camurri ◽  
Gerarda Pompella ◽  
Alessia Mazzola ◽  
Massimo Maccherini ◽  
...  

2007 ◽  
Vol 22 (3) ◽  
pp. 851-856 ◽  
Author(s):  
L. Carrega ◽  
E. Fenouillet ◽  
P. Giaime ◽  
A. Charavil ◽  
L. Mercier ◽  
...  

2016 ◽  
Vol 22 (21) ◽  
pp. 3082-3096 ◽  
Author(s):  
Aliuska Morales Helguera ◽  
Yunierkis Perez-Castillo ◽  
M. Natália D.S. Cordeiro ◽  
Eduardo Tejera ◽  
César Paz-y-Miño ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document